Toll-Like Receptors 2 and 4 Cooperate in the Control of the Emerging Pathogen Brucella microti by Arias Cabrero, Maykel Alberto et al.
ORIGINAL RESEARCH
published: 09 January 2017
doi: 10.3389/fcimb.2016.00205
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 1 January 2017 | Volume 6 | Article 205
Edited by:
Philip R. Hardwidge,
Kansas State University, USA
Reviewed by:
Jeff Shannon,
National Institute of Allergy and
Infectious Diseases (NIH), USA
Christian Rueter,
Universitätsklinikum Münster,
Germany
*Correspondence:
Maria P. Jiménez De Bagüés
mpjimenezdebagues@aragon.es
Julián Pardo
pardojim@unizar.es
†
Present Address:
Marina Freudenberg,
BIOSS Centre for Biological Signalling
Studies, Albert-Ludwigs-Universität
Freiburg, Freiburg, Germany
‡
These authors have contributed
equally to this work.
Received: 14 October 2016
Accepted: 22 December 2016
Published: 09 January 2017
Citation:
Arias MA, Santiago L,
Costas-Ramon S, Jaime-Sánchez P,
Freudenberg M, Jiménez De
Bagüés MP and Pardo J (2017)
Toll-Like Receptors 2 and 4
Cooperate in the Control of the
Emerging Pathogen Brucella microti.
Front. Cell. Infect. Microbiol. 6:205.
doi: 10.3389/fcimb.2016.00205
Toll-Like Receptors 2 and 4
Cooperate in the Control of the
Emerging Pathogen Brucella microti
Maykel A. Arias 1, Llipsy Santiago 1, Santiago Costas-Ramon 1, Paula Jaime-Sánchez 1,
Marina Freudenberg 2†, Maria P. Jiménez De Bagüés 3*‡ and Julián Pardo 1, 4, 5*‡
1Cell Immunity in Cancer, Inflammation and Infection Group, Department of Biochemistry and Molecular and Cell Biology,
Biomedical Research Centre of Aragon (CIBA), IIS Aragon, University of Zaragoza, Zaragoza, Spain, 2Max-Planck Institute for
Immunobiology and Epigenetics, Freiburg, Germany, 3Unidad de Producción y Sanidad Animal, Centro de Investigación y
Tecnología Agroalimentaria, Instituto Agroalimentario de Aragón – IA2, CITA-Universidad de Zaragoza, Zaragoza, Spain,
4Nanoscience Institute of Aragon, University of Zaragoza, Zaragoza, Spain, 5 Aragon I+D Foundation, Zaragoza, Spain
Toll-like receptors (TLRs) recognize pathogen-derived molecules and play a critical role
during the host innate and adaptive immune response. Brucella spp. are intracellular
gram-negative bacteria including several virulent species, which cause a chronic zoonotic
infection in a wide range of mammalian hosts known as brucellosis. A new Brucella
species, Brucella microti, was recently isolated from wild rodents and found to be
highly pathogenic in mice. Using this species-specific model, it was previously found
that CD8+ T cells are required to control this infection. In order to find out the role
of TLR-mediated responses in the control of this pathogen, the course of infection
of B. microti was analyzed over 3 weeks in wild-type (WT) and TLR knock out (KO)
mice including TLR2−/−, TLR4−/−, TLR9−/−, TLR2×4−/− and TLR2×4 −×9 /−. WT
and single TLR2, TLR4 and TLR9 KO mice similarly control infection in liver and
spleen. In contrast, bacterial clearance was delayed in TLR2×4−/− and TLR2 4 /×9− −×
mice at 7 and 14 days post-infection. This defect correlated with impaired maturation
and pro-inflammatory cytokine production in B. microti-infected dendritic cells from
TLR2×4−/− and TLR2 −×4 /×9− mice. Finally, it was found that Tc cells from TLR2×4−/−
and TLR2×4×9−/− mice showed reduced ability to inhibit growth of B. microti in
macrophages, suggesting the involvement of TLR2 and 4 in the generation of specific
Tc cells. Our findings indicate that TLR2 and TLR4 are required to control B. microti
infection in mice and that this effect could be related to its participation in the maturation
of dendritic cells and the generation of specific CD8+ Tc cells.
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INTRODUCTION
The genus Brucella are Gram-negative facultative intracellular pathogens capable of infecting a
variety of hosts, causing the worldwide zoonosis known as brucellosis (Franco et al., 2007). This
genus consists of several species, which differ mainly in their host preference and it has been
traditionally classified into 6 species B. melitensis, B. suis, B. abortus, B. neotomae, B. ovis, and
B. canis (Godfroid et al., 2005, 2011). Recently new species have been discovered including B. ceti
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and B. pinnipedialis, isolated from cetacean and pinniped species
(Foster et al., 2007), and B. inopinata isolated from a human
breast implant (De et al., 2008; Scholz et al., 2010).
B. microti, a new species originally isolated from the common
vole and later on from the red fox and from soil (Scholz et al.,
2008a,b, 2009; Al Dahouk et al., 2012), is the first one found to be
highly pathogenic in mice (Jiménez de Bagüés et al., 2011; Arias
et al., 2014). In addition, it is able to cause sepsis in C57BL/6
mice (Arias et al., 2014). These results suggest that B. microti
is an emergent pathogen that represents a biologically relevant
tool to study Brucella pathogenesis and host immunity in mouse
models. In contrast to this novel Brucella spp., experimental
infection of mice with the same doses of classical Brucella spp.
like B. melitensis, B. abortus or B. suis or with the new ones B. ceti
and B. pinnipedialis leads to a typical replication pattern in the
spleen and liver, characterized by a multiplication phase until the
number of bacteria reaches its maximum (acute phase), followed
by a chronic plateau phase and a declining phase that ends by
the clearing of the bacteria in both organs. The duration of these
phases depends on the route and the dose of the inoculum and
the chronic phase can last more than 20 weeks (Montaraz and
Winter, 1986; Edmonds et al., 2002; Abdou et al., 2013; Nymo
et al., 2016). None of the classical Brucella spp. are pathogenic for
the mouse at doses at which B. microti shows high pathogenicity.
Recognition of pathogen-associated molecular patterns
(PAMPs) by pattern recognition receptors (PRRs) is the first line
of defense involved in the generation of an immune response
against infection. This process activates intracellular signaling
cascades that culminate in gene activation and production
of inflammatory cytokines, chemokines, and co-stimulatory
molecules (Kawai and Akira, 2007). The Toll-Like Receptor
(TLR) family is the major and most extensively studied class of
PRRs (Takeuchi and Akira, 2010). Ten human and 12 murine
TLRs have been identified (Akira et al., 2006), which recognize
both intracellular and extracellular PAMPs. TLRs 1, 2, 4, 5, 6,
and 11 are expressed on the cell membrane, meanwhile TLRs 3,
7, 8, and 9 are located in intracellular endosomes (Sabroe et al.,
2008; Kawai and Akira, 2011). They are expressed on a wide
range of cell types including dendritic cells, macrophages, B and
T cells, natural killer (NK) cells as well as in cells from non-
hematopoietic origin like endothelial cells, epithelial cells and
fibroblasts. Regarding their PAMP specificity, TLR2 recognizes
a wide array of microbial molecules like bacterial lipotechoic
acid, peptidoglycan and lipoproteins, viral hemagglutinin and
yeast polysaccharides (Lewis et al., 2012). TLR4 recognizes LPS
(from Gram-negative bacteria) and several viral envelop proteins
(Hoshino et al., 1999; Takeda and Akira, 2005; Tsujimoto et al.,
2008). TLR5 recognizes flagellin, presented in motile bacteria
such as Salmonella spp. (Andersen-Nissen et al., 2007) and TLR3,
TLR7, TLR8, and TLR9 recognize nucleic acids derived from
viruses and bacteria (Akira et al., 2006). All TLRs also recognize
endogenous ligands during inflammatory and autoimmune
diseases.
Brucella spp. are able to colonize host macrophages, avoiding
the immune response and establishing a chronic infection
(Baldwin and Goenka, 2006; Gorvel, 2008; Seleem et al., 2008).
Using B. abortus and B. melitensis, it was found that dendritic
cells, macrophages and CD8+ T cells (Oliveira and Splitter, 1995;
Copin et al., 2007; Macedo et al., 2008; Salcedo et al., 2008) are
the key components of the host cellular immunity to control
infection in mouse models. The role of TLRs in Brucella infection
has been investigated in mouse models utilizing classical Brucella
species including B. abortus (Campos et al., 2004; Huang et al.,
2005; Weiss et al., 2005; Barquero-Calvo et al., 2007; Macedo
et al., 2008; de Almeida et al., 2013), B. melitensis (Copin et al.,
2007) and B. ovis (Vieira et al., 2013). However, the role of TLRs
during infection with a mouse specific species like B. microti is
still unknown.
We have previously shown that CD8+ T cells are involved in
the control of B. microti infection in mice (Jiménez de Bagüés
et al., 2011; Arias et al., 2014). We have now analyzed the role of
TLR2, TLR4 and TLR9 in the control of B. microti infection and
found that in vivo TLR2 and TLR4 cooperate to eliminate this
pathogen, while TLR9 is dispensable to control the infection. The
implication of TLR2 and 4 in the control of the infection seems to
be related to the generation of anti-bacterial CD8+ T cell activity
and the maturation of dendritic cells, including the production of
pro-inflammatory cytokines.
EXPERIMENTAL PROCEDURES
Mouse Strains
Inbred C57BL/10 (WT B10) (Janvier Laboratories, France), and
mouse strains deficient for Toll Like Receptor 2 (TLR2−/−),
4 (TLR4−/−), 9 (TLR9−/−), 2 and 4 (TLR2×4−/−) and 2,
4, and 9 (TLR2×4×9−/−) were kindly provided by Marina
Freudenberg from the Max-Planck-Institute for Immunobiology
and Epigenetics, Freiburg and bred at Animal facilities of
the CITA. Their genotypes were analyzed as described (Pardo
et al., 2008). Eight to twelve weeks old mice were used in
all experiments. Animal experimentation was approved by
the Ethics Committee for Animal Experimentation from the
CITA (number 2011/01).
Bacterial Strain and Determination of CFU
B. microti strain CCM 4915 (Jiménez de Bagüés et al., 2011)
was used in all experiments. It was grown to stationary phase
in tryptic soy broth (Difco), with shaking, at 37◦C. The number
of living bacteria in a sample was determined by counting the
CFU after plating serial dilutions onto tryptic soy agar plates as
described previously (Jiménez de Bagüés et al., 2011). In addition,
the smooth phenotype of the strain was verified in all cases by
crystal violet staining (Jiménez de Bagüés et al., 2010).
Replication of Brucella microti In vivo
A sublethal dose (105 CFU) of B. microti was injected
intraperitoneally (ip) and, at different time points, mice were
euthanized by CO2 asphyxiation and blood, spleen, and
liver samples were collected aseptically. Organs were weighed,
homogenized, serially diluted in PBS, plated onto tryptic soy agar
and incubated 48 h at 37◦C for determining the number of viable
Brucella organisms.
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Isolation of Tc Cells from Spleen
WTB10mice andmice deficient in TLR 2, TLR 4, and TLR 9were
infected with a sublethal dose of B. microti (105 CFU) ip. After 7
days CD8+ (Tc) cells were positively selected from spleen using
anti-CD8-MicroBeads and autoMACS (Miltenyi Biotec, Spain).
Finally, Tc cells were resuspended in DMEM supplemented with
10% of inactivated fetal calf serum (FCS) containing 30µg/ml of
gentamicin before using them in different assays.
Intracellular Expression of Granzyme B
Intracellular expression of granzyme B in MACS-enriched Tc
cells was analyzed by FACS as previously described (Joeckel et al.,
2011). Prior to the first staining step cells were incubated with
anti(a)-FcR-antibody (clone 2.4G2) to avoid unspecific stainings.
Rabbit immune serum (IS) specific for mouse gzmB (a-mgzmB)
has been previously described (Joeckel et al., 2011).
Replication of Brucella microti in Bone
Marrow Derived Macrophages (BMDM)
Macrophages were differentiated from mouse bone marrow
(BM) as previously described (Aporta et al., 2012). Briefly, cells
were aseptically collected from bone marrow and resuspended
in DMEM supplemented with 10% of inactivated FCS, 2mM
glutamine, 5% of inactivated horse serum and 10% supernatant
of L-929 cell cultures as source of M-CSF. Cells were seeded at a
density of 1× 106 cells/ml and allowed to differentiate for 6 days
at 37◦C and 5% CO2. At day 6 macrophages were used for the
different experiments. Cell cultures contained more than 90% of
CD11b+/CD11c− cells analyzed by flow cytometry, confirming
the macrophage identity of cells.
For replication experiments in vitro 4×105 macrophages/well
were seeded in 24 well plates, infected with B. microti at a
multiplicity of infection (MOIs) of 25:1 and incubated for 45min
at 37◦C, in a 5% CO2 atmosphere. At this time point enriched
Tc from WT or KO mice were added at 5:1 ratio. Subsequently,
medium was removed, cells were washed with PBS and further
incubated with complete DMEM medium containing 30µg/ml
of gentamycin. After 24 h macrophages were lysed with 0.1%
of Triton-X100 and Brucella CFU number was determined by
dilution plating.
Generation of BM-Derived Dendritic Cells,
BMDCs
DCs were generated from bone marrow cells using wild-type
C57BL/10, TLR2−/−, TLR4−/−, TLR9−/−, TLR2×4−/−,
TLR2×4×9−/− and MyD88−/− mice, in RPMI 1640
medium containing 10% of FCS serum, 100 U/ml of
penicillin/streptomycin, 50mMof 2-ME, and 10% of supernatant
of X63Ag8653 cell cultures as source of GM-CSF (Zal et al.,
1994) (DC medium). Cells were cultured on 100mm petri dishes
(1 × 106 cells/10ml DC culture medium). On days 2 and 4,
the cell medium was refreshed and, on day 6, cells showed
differentiated morphology and expressed the DC markers
CD11c+, MHC class II (MHCII) low and CD40 low (d
r
ata not
shown), confirming their identity as immature DCs.
Replication of B. microti in BMDC
For in vitro B. microti infection experiments 4 × 105 DC were
seeded in 24 well plates and infected with B. microti at a MOIs
of 25:1 for 45min at 37◦C, 5% CO2. Subsequently, medium was
removed, cells were washed with PBS and further incubated with
complete RPMI medium containing 30µg/ml of gentamycin.
After 1.5, 24, and 48 h DC were lysed with Triton-X 0.1%
and CFU number was determined. At each time supernatants
were collected and the levels of TNFα and IL-6 were measured
employing commercial ELISA kits (eBiocience).
Analysis of BMDC Maturation
To analyze DC maturation, BMDC were stimulated for 24 h
with E. coli-derived LPS (1µg/ml) or heat killed B. microti
(HKBM; 100 bacteria/cell). Subsequently, the expression of
MHCII, CD40, CD86 and CD80 was analyzed on CD11c+ cells
using MHCII-APC, CD40-APC, CD86-FITC, CD80-FITC and
CD11c-PE antibodies (Miltenyi Biotec). Samples were fixed with
4% PFA and analyzed by flow cytometry using a FACSCalibur
flow cytometer (BD Biosciences).
Statistical Analyses
Statistical analysis was performed using GraphPad Prism
software. The difference between means of three or more
independent groups was performed using one-way ANOVA
test with Bonferroni’s post-test. The results are given as the
confidence interval (p), and are considered significant when
P < 0.05. Biological replicates are considered as the number of
individual mice.
RESULTS
TLR2 and TLR4 Cooperate to Control
B. microti infection In vivo
In order to analyze the role of TLR2 and TLR4 in the control
of B. microti infection, WT B10, TLR2−/−, TLR4−/− and
TLR2×4−/− mice were infected ip with a sublethal dose (105
cfu) of B. microti and bacterial load was determined in spleen and
liver 3, 7, 14, and 21 days after infection. As shown in Figure 1,
bacterial clearance was delayed in TLR2×4−/− mice compared
with WT B10 mice. The absence of either TLR2 or TLR4 did not
affect bacterial clearance.
By day 3, the time of maximum bacterial load, no differences
were found between the different animal groups. However,
significant differences were found between WT B10 and
TLR2×4−/− mice in spleen and liver after 7 days, time
after which wild type animals began to clear infection. The
differences between the two groups were less pronounced, but
still significant, after 14 days. No differences were found anymore
between the different groups after 21 days.
TLR9 Is Not Required to Control B. microti
infection
Our results indicate that in vivo both TLR2 and 4 are required for
the early control of B. microti replication. Previous works have
shown that TLR9 is involved in the early control of B. ovis and
B. abortus infection. Thus, we decided to analyze the role of TLR9
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in the control of B. microti infection. In this experiment bacterial
replication was only analyzed after 7 and 14 days of infection,
times after which significant differences were found betweenWT
B10 and TLR2×4−/− mice.
As shown in Figure 2 bacterial load was significantly higher
in spleen and liver of TLR2×4−/− and TLR2×4×9−/− mice
compared to WT B10 mice. No differences were found between
WT B10 and TLR9−/− mice. In addition, bacterial replication
was similar in TLR2×4−/− and TLR2×4×9−/− mice, indicating
that TLR9 does not play any role in the control of B. microti
infection.
Replication of B. microti and Cytokine
Production in BMDC from Mice Deficient in
TLR2, TLR4 and TLR9
Several TLRs are involved in the activation and maturation of
dendritic cells by classical Brucella spp. (Campos et al., 2004;
Huang et al., 2005; Weiss et al., 2005; Barquero-Calvo et al.,
2007; Copin et al., 2007; Macedo et al., 2008; de Almeida et al.,
2013). Thus, we decided to analyze the role of TLR2, TLR4
and TLR9 in DC activation and maturation after B. microti
infection in vitro. First, we analyzed if DC from mice deficient
in the different TLRs failed to produce Th1 polarizing pro-
inflammatory cytokines after B. microti infection, a critical step
to further induce the activation of T cell responses against
intracellular pathogens.WTB10, TLR2−/−, TLR4−/−, TLR9−/−,
TLR2×4−/− and TLR2×4×9−/− BMDCs were infected with
B. microti at a MOI:25 and production of TNFα and IL6 as
well as bacterial replication were determined after 24 and 48 h
(Figure 3).
As shown in Figures 3A,B, the absence of either TLR2 or
TLR4 significantly reduced the production of TNFα (Figure 3A)
and IL6 (Figure 3B) after 24 and 48 h of infection. TLR9
deficiency did not affect TNFα production and only slightly
reduced IL6 generation. When TLR2 and TLR4 or TLR2, TLR4
and TLR9 were absent, TNFα and IL6 generation was reduced to
basal (non-stimulated control) levels.
FIGURE 1 | The absence of both TLR2 and 4 affects the control of B. microti infection in spleen and liver. TLR2−/−, TLR4−/− and TLR2×4−/− mice were
infected i.p. with B. microti (105 CFU) and the number of CFU in spleen and liver was determined 3, 7, 14, or 21 days later. Data are presented as mean ± SEM of
10–25 biological replicates performed in 4 independent experiments; Statistical analyses was performed by one-way ANOVA test with Bonferroni’s post-test.
***P < 0.001, comparing each group with the control group (WT B10).
FIGURE 2 | TLR9 is not necessary for the control of B. microti infection in spleen and liver. WT B10, TLR9−/−, TLR2×4−/− and TLR2×4×9−/− mice were
infected i.p. with B. microti (105 CFU) and the number of CFU in spleen and liver was determined 7 and 14 days later. Data are presented as mean ± SEM of 7–12
biological replicates performed in 2 independent experiments; Statistical analyses was performed by one-way ANOVA test with Bonferroni’s post-test. *P < 0.05;
**P < 0.01; ***P < 0.001, comparing each group with the control group (WT B10).
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FIGURE 3 | Replication of B. microti in BMDC and cytokine production in BMDC deficient in TLR2, TLR4 and TLR9. 4× 105 BMDC from WT B10,
TLR2−/−, TLR4−/−, TLR9−/−, TLR2×4−/− or TLR2×4×9−/− mice were infected with B. microti (MOI 25:1) for 45min and, subsequently, cells were washed with
PBS and further incubated with RPMI 10% FCS containing 30µg/ml of gentamycin. (A,B) After 24 and 48 h of infection cell culture supernatants were collected and
the levels of TNFα (A) and IL-6 (B) were measured by ELISA. (C) After 1.5, 24, and 48 h DC were lysed with Triton-X 0.1% and CFU number was determined as
indicated in materials and methods. Statistical analyses was performed by one-way ANOVA test with Bonferroni’s post-test. **P < 0.01; ***P < 0.001, comparing
each group with the control group (WT B10).
These differences were not due to different levels of
intracellular B. microti since entry and replication of B. microti
(Figure 3C) was not affected by TLR deficiency.
Role of TLR2, TLR4 and TLR9 in BMDC
Maturation
Next we analyzed the role of TLR2, TLR4 and TLR9 in the
maturation of DC, another key step to control intracellular
bacterial replication.
BM-derived DCs fromWT and TLRKOmice were stimulated
with E. coli LPS or with heat killed B. microti (HKBM) and
cell surface expression of CD40, CD80, CD86 and MHC-II was
analyzed on CD11c+ cells. In comparison with control non-
stimulated cells, BMDC from WT mice stimulated with LPS
or HKBM showed enhanced expression of CD40 (Figure 4A),
CD80 (Figure 4B), CD86 (Figure 4C) and MHC-II (Figure 4D),
confirming the generation of mature DCs. A similar maturation
profile was observed in TLR2−/−, TLR4−/− or TLR9−/− DCs
stimulated with HKBM. As expected, stimulation with LPS did
not increase expression of these markers in DCs from TLR4−/−
mice. The absence of TLR2 and 4 or TLR2, 4, and 9 significantly
reduced the expression of the maturation markers in DC,
confirming that TLR2 and TLR4 are involved in DC activation
and maturation.
B. microti-Specific Ex vivo Tc Cells from
Mice Deficient in TLR2 and TLR4 Show a
Lower Capacity to Block B. microti
Replication in BMDM
Finally, we analyzed if impaired maturation of DC from TLR2,
4 and 9 deficient mice, correlated with a reduced ability to
activate B. microti-specific CD8+ Tc cell responses during in vivo
infection. We have previously shown that CD8+ T cells are
involved in the control B. microti infection in vivo as well as in
macrophages in vitro and, thus, defective control of infection
observed in the absence of TLR2 and TLR4 could be related
with a lower generation of B. microti-specific CD8+ Tc cells
(Arias et al., 2014). WT B10, TLR2−/−, TLR4−/−, TLR9−/−,
TLR2×4−/− and TLR2×4×9−/− mice were infected with a
sublethal doses (105 CFU ip) of B. microti and, 7 days later,
CD8+ cells from spleen were enriched by MACS and incubated
with B. microti-infected macrophages. As shown in Figure 5,
bacterial growth was significantly reduced by CD8+ T cells from
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FIGURE 4 | TLR2 and TLR4 are involved in BMDC maturation induced by HKBM. BMDCs from WT B10, TLR2−/−, TLR4−/−, TLR9−/−, TLR2×4−/− and
TLR2×4×9−/− mice were stimulated with E. coli LPS or HKBM for 24 h and, subsequently, cell surface expression of CD40 (A), CD80 (B), CD86 (C), and MHCII (D)
on CD11c+ cells was analyzed by flow cytometry. A representative experiment is shown as histograms. Numbers show the percentage of positive cells as gated by
the vertical bars. Control non-stimulated cells were used as reference for marker expression. Graphs represent the mean ± SEM from two independent experiments
performed by duplicates. Statistical analyses was performed by one-way ANOVA test with Bonferroni’s post-test. **P < 0.01; ***P < 0.001 as indicated.
WT, TLR2−/−, TLR4−/− or TLR9−/− deficient mice. In contrast,
bacteria replicated significantly higher in macrophages incubated
with CD8+ T cells from TLR2×4−/− or TLR2×4×9−/− mice,
confirming a defect in the anti-bacterial activity of CD8+ T cells
in the absence of TLR2 and TLR4.
This defect was not due to a reduced activation of CD8+
T cells since cells from WT and TLR KO mice expressed
similar levels of the cytotoxic activation marker granzyme B
(Figure 5B).
DISCUSSION
B. microti is new atypical Brucella species, highly pathogenic in
mice, that causes bacterial sepsis and death (Jiménez de Bagüés
et al., 2010; Arias et al., 2014). We have previously found that
adaptive T and B cell responses are required to efficiently control
B. microti infection in mice (Jiménez de Bagüés et al., 2011). In
this work, we have analyzed the role of TLR2, TLR4 and TLR9,
the main receptors within the TLR family involved in the control
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FIGURE 5 | B. microti- specific ex vivo Tc cells from mice lacking TLR2 and TLR4 show a lower capacity to inhibit B. microti replication in BMDM. (A)
WT B10, TLR2−/−, TLR4−/−, TLR9−/−, TLR2×4−/− and TLR2×4×9−/− mice were infected with B. microti i.p. (105 cfu). Seven days later, CD8+ cells were
enriched from spleen using MACS and incubated with BMDM from WT B10 mice infected with B. microti. After 24 h, cells were lysed and the number of CFU was
determined. Data are presented as mean ± SEM from three independent experiments performed by triplicates. Statistical analyses was performed by one-way
ANOVA test with Bonferroni’s post-test. **P < 0.01, comparing each group with the group treated with WT B10 Tc cells. (B) Intracellular expression of granzyme B
was analyzed in MACS-enriched CD8+ cells. A representative experiment from two independent studies is shown.
of classical Brucella spp., during B. microti infection. We have
found that TLR2 and TLR4 cooperate in the early control of
this infection, while TLR9 is dispensable. At later stages, all mice
control infection and compensate for the lack of TLR2 and TLR4
by additional unknown mechanisms.
The role of TLRs in the control of B. microti infection
seems to be different from classical Brucella spp. While TLR9
is important in host defense against B. abortus (Macedo et al.,
2008), B. melitensis (Copin et al., 2007) and B. ovis (Vieira et al.,
2013), our data show that TLR9 is not necessary for the control
of B. microti infection in mice. In contrast, TLR2 and TLR4
cooperate for controlling B. microti infection, while it has been
previously reported that TLR2 does not play any role in host
defense against B. abortus, B. melitensis, and B. ovis (Weiss et al.,
2005; Copin et al., 2007; Vieira et al., 2013). Concerning the role
of TLR4 in the control of classical Brucella spp., contradictory
findings have been reported. Some works indicate that TLR4
participates in host defense against B. melitensis (Copin et al.,
2007) and B. abortus (Campos et al., 2004), but others indicate
that both TLR4 and TLR2 are dispensable for the control of B.
abortus infection (Weiss et al., 2005; Barquero-Calvo et al., 2007).
The differences found concerning the participation of TLR2
and TLR4 in the control of B. microti and classical Brucella
spp., might be related to the different composition of TLR
ligands expressed by novel and classical species. Supporting this
hypothesis, in contrast to B. microti, classical Brucella spp. do
not induce sepsis in animal models. This is likely related to
the composition of LPS in the classical species that differs from
the conventional LPS structure found in other gram(-) bacterial
pathogens (Cardoso et al., 2006). In this regard, it has been shown
that the core-lipid A moiety of LPS of B. microti is different from
classical Brucella spp., although its ability to activate TLR4 has
not been tested yet (Zygmunt et al., 2012). Further supporting
this hypothesis, it is well known that TLR2 and TLR4 are crucial
in host defense against several bacterial pathogens that, like
B. microti, cause sepsis like Staphylococcus aureus, Streptococcus
pneumoniae (Takeuchi et al., 2000; Dessing et al., 2008),Klebsiella
pneumoniae (Schurr et al., 2005), Haemophillus influenza (Wang
et al., 2002) and Acinetobacter baumanii (Knapp et al., 2006).
Concerning TLR2, it is well known that lipoproteins (the
main TLR2 ligands) expressed by classical Brucella spp. are
poor activators of innate immune responses (Olsen and Palmer,
2014). Thus, it is tempting to speculate that B. microti could
express lipoproteins that would activate TLR2-related responses
more efficiently than those activated by lipoproteins expressed in
classical Brucella spp. However, more experiments are required
to confirm this hypothesis.
What would the impact be of TLR2 and TLR4 deficiency on
the generation of adaptive immune responses during B. microti
infection? Our group has previously found that CD8+ Tc
cells are also required to control B. microti infection (Arias
et al., 2014). We have now shown that Tc cells from mice
lacking TLR2 and TLR4 show a lower capacity to abrogate
B. microti replication in BMDMs-infected cells. The inability of
ex vivo TLR2×4−/− mice-derived Tc cells to block B. microti
replication in BMDM seems to be related to impaired dendritic
cell maturation. Interestingly, Tc cells from TLR2×4−/− mice
do not present any in vivo defect in activation, as shown by
gzmB intracellular expression that is similar in Tc cells from WT
and TLR2×4−/− mice. Clonal expansion and development of
cytotoxic function (i.e., gzmB) in CD8+ T cells requires three
independent signals: (a) Ag presentation, (b) co-stimulation,
and (c) IL-12 or adjuvant (Curtsinger et al., 2003). During the
maturation process, DC enhance their Ag presenting ability
and prime T cells by up-regulating cell surface MHCII and the
CD40, CD80 and CD86 co-stimulatory molecules (Macedo et al.,
2008) (signals 1 and 2). However, the acquisition of cytotoxic
capacity is only dependent on IL-12 (signal 3) (Curtsinger et al.,
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2003). Thus, our results might indicate that TLR2 and TLR4
would participate in DC maturation (signals 1 and 2), but not
in the production of IL12 (signal 3). However, this hypothesis
would need further experimental validation, which is out of the
scope of the present work. Altogether it seems that the reduced
capacity of Tc from TLR2×4 deficient mice to abrogate the
replication of B. microti in BMDM might be related to a lower
generation of B. microti-specific Tc cells due to impairment in DC
maturation.
In conclusion, TLR2 and TLR4 cooperate to control B. microti
infection in mice by a mechanism that seems to be dependent
on DC maturation and generation of specific B. microti CD8+
Tc cells. This finding provides more insights into the control of a
novel emerging species of the Brucella genus and advises caution
when interpreting the mechanisms involved in host-pathogen
interaction, using non-specific pathogens of this bacterial
genus.
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